Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis

Stem Cells

Volumn 25, Issue 10, 2007, Pages 2648-2659

  Wu, Yaojiong ^a   Chen, Liwen ^a   Scott, Paul G ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ang 1; Angiogenesis; Diabetic mice; Regeneration repair; Vascular endothelial growth factor

Indexed keywords

GREEN FLUORESCENT PROTEIN; KERATIN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CD34 SELECTION; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTER; KERATINOCYTE; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; TISSUE REGENERATION; WOUND HEALING;

ANGIOGENIC PROTEINS; ANIMALS; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; FEMALE; FIBROBLASTS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; KERATINS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; RANDOM ALLOCATION; SKIN; TRANSPLANTATION, HOMOLOGOUS; WOUND HEALING; WOUNDS AND INJURIES;

MUS;

EID: 35348831024     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0226     Document Type: Article

References (44)

1. Martin P. Wound healing - Aiming for perfect skin regeneration. Science 1997;276:75-81.
2. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005;366:1736-1743.
3. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-746.
4. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G et al. The global burden of diabetic foot disease. Lancet 2005;366:1719-1724.
5. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
6. Sato Y, Araki H, Kato J et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;106:756-763.
7. Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98.
8. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999;96:10711-10716.
9. Kondo T, Johnson SA, Yoder MC et al. Sonic hedgehog and retinoic acid synergistically promote sensory fate specification from bone marrow-derived pluripotent stem cells. Proc Natl Acad Sci U S A 2005;102:4789-4794.
10. Amado LC, Saliaris AP, Schuleri KH et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005;102:11474-11479.
11. Jin HK, Carter JE, Huntley GW et al. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J Clin Invest 2002;109:1183-1191.
12. Li Y, Chen J, Zhang CL et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005;49:407-417.
13. Keating A. Mesenchymal stromal cells. Curr Opin Hematol 2006;13:419-425.
14. Colter DC, Class R, DiGirolamo CM et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A 2000;97:3213-3218.
15. Fathke C, Wilson L, Hutter J et al. Contribution of bone marrow-derived cells to skin: Collagen deposition and wound repair. STEM CELLS 2004;22:812- 822.
16. Tropel P, Noel D, Platet N et al. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 2004;295:395-406.
17. Baghdoyan S, Lamartine J, Castel D et al. Id2 reverses cell cycle arrest induced by gamma-irradiation in human HaCaT keratinocytes. J Biol Chem 2005;280:15836-15841.
18. Galiano RD, Michaels V, Dobryansky M et al. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 2004;12:485-492.
19. Jacobi J, Jang JJ, Sundram U et al. Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 2002;161:97-104.
20. Galeano M, Altavilla D, Cucinotta D et al. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 2004;53:2509-2517.
21. Yoon YS, Murayama T, Gravereaux E et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 2003;111:717-725.
22. Hamano Y, Zeisberg M, Sugimoto H et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaVbeta3 integrin. Cancer Cell 2003;3:589-601.
23. Borue X, Lee S, Grove J et al. Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 2004;165:1767-1772.
24. Fukushi Ji, Makagiansar IT, Stallcup WB. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell 2004;15:3580-3590.
25. Miller GE, Chen E. Life stress and diminished expression of genes encoding glucocorticoid receptor and β2-adrenergic receptor in children with asthma. Proc Natl Acad Sci U S A 2006;103:5496-5501.
26. Wu Y, Chen L, Zheng PS et al. β1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J Biol Chem 2002;277:12294-12301.
27. Du Z, Podsypanina K, Huang S et al. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Proc Natl Acad Sci U S A 2006;103:17396-17401.
28. Wu Y, Ip JE, Huang J et al. Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circ Res 2006;99:315-322.
29. Grutzkau A, Kruger-Krasagakes S, Baumeister H et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: Implications for the biological significance of VEGF206. Mol Biol Cell 1998;9:875-884.
30. McFarlin K, Gao X, Liu YB et al. Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen 2006;14:471-478.
31. Li H, Fu X, Ouyang Y et al. Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res 2006;326:725-736.
32. Spees JL, Olson SD, Ylostalo J et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci U S A 2003;100:2397-2402.
33. Noiseux N, Gnecchi M, Lopez-Ilasaca M et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006;14:840-850.
34. Arnold F, West DC. Angiogenesis in wound healing. Pharmacol Ther 1991;52:407-422.
35. Fam NP, Verma S, Kutryk M et al. Clinician guide to angiogenesis. Circulation 2003;108:2613-2618.
36. Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-1549.
37. Gnecchi M, He H, Liang OD et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005;11:367-368.
38. Wang G, Bunnell BA, Painter RG et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: Potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A 2005;102:186 -191.
39. Medina RJ, Kataoka K, Miyazaki M et al. Efficient differentiation into skin cells of bone marrow cells recovered in a pellet after density gradient fractionation. Int J Mol Med 2006;17:721-727.
40. Stepanovic V, Awad O, Jiao C et al. Leprdb diabetic mouse bone marrow cells inhibit skin wound vascularization but promote wound healing. Circ Res 2003;92:1247-1253.
41. Zuloff-Shani A, Kachel E, Frenkel O et al. Macrophage suspensions prepared from a blood unit for treatment of refractory human ulcers. Transfus Apher Sci 2004;30:163-167.
42. Griffith LG, Naughton G. Tissue engineering - Current challenges and expanding opportunities. Science 2002;295:1009-1014.
43. Hasegawa T, Suga Y, Mizoguchi M et al. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: Three case reports. J Dermatol 2005;32:715-720.
44. Lamme EN, Van Leeuwen RTJ, Mekkes JR et al. Allogeneic fibroblasts in dermal substitutes induce inflammation and scar formation. Wound Repair Regen 2002;10:152-160.